Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is PROCHLORPERAZINE MALEATE USP, with a corresponding US DMF Number 36173.
Remarkably, this DMF maintains an Active status since its submission on August 27, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2021, and payment made on August 17, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II